

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.67542680 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.77219747 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.77219747 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.77219747 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.77219747 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.77219747 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.77219747 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.61998503 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.56440359 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.27976740 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.17840048 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.12153654 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.10790686 |
| 14 | detection of other organism (GO:0098543) | 4.02504096 |
| 15 | positive regulation of antigen processing and presentation (GO:0002579) | 3.96121245 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 3.86811345 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.86362052 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.86362052 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.84365226 |
| 20 | detection of bacterium (GO:0016045) | 3.83765148 |
| 21 | response to peptidoglycan (GO:0032494) | 3.63035704 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55507533 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.54977937 |
| 24 | neutrophil activation (GO:0042119) | 3.51478924 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.50481639 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.49370590 |
| 27 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.49358533 |
| 28 | natural killer cell mediated immunity (GO:0002228) | 3.49358533 |
| 29 | granulocyte activation (GO:0036230) | 3.43690278 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42484883 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.41047053 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.40332676 |
| 33 | respiratory burst (GO:0045730) | 3.38387116 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35097075 |
| 35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.28955051 |
| 36 | regulation of cholesterol storage (GO:0010885) | 3.28691773 |
| 37 | regulation of antigen processing and presentation (GO:0002577) | 3.27682711 |
| 38 | negative T cell selection (GO:0043383) | 3.26541553 |
| 39 | pinocytosis (GO:0006907) | 3.24970055 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.18574508 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.18408041 |
| 42 | negative regulation of granulocyte differentiation (GO:0030853) | 3.17832618 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14391825 |
| 44 | response to type I interferon (GO:0034340) | 3.12667315 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11397763 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10295476 |
| 47 | detection of biotic stimulus (GO:0009595) | 3.09260386 |
| 48 | cellular response to type I interferon (GO:0071357) | 3.07965101 |
| 49 | type I interferon signaling pathway (GO:0060337) | 3.07965101 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06925590 |
| 51 | leukocyte aggregation (GO:0070486) | 3.06386107 |
| 52 | cellular extravasation (GO:0045123) | 3.04456315 |
| 53 | defense response to protozoan (GO:0042832) | 3.04299431 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03502899 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03394595 |
| 56 | B cell mediated immunity (GO:0019724) | 3.02858174 |
| 57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.01784525 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00381445 |
| 59 | positive regulation of interferon-beta production (GO:0032728) | 2.99518182 |
| 60 | response to host immune response (GO:0052572) | 2.99446882 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99446882 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 2.99268210 |
| 63 | T cell selection (GO:0045058) | 2.99038942 |
| 64 | response to interleukin-15 (GO:0070672) | 2.92110735 |
| 65 | neutrophil mediated immunity (GO:0002446) | 2.91711793 |
| 66 | thymic T cell selection (GO:0045061) | 2.90954621 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 2.88672401 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.87094764 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87023872 |
| 70 | negative regulation of lipid storage (GO:0010888) | 2.86673810 |
| 71 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84582039 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84181306 |
| 73 | positive T cell selection (GO:0043368) | 2.83830083 |
| 74 | lipoprotein transport (GO:0042953) | 2.82904162 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82874150 |
| 76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82386909 |
| 77 | regulation of tolerance induction (GO:0002643) | 2.82156715 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 2.79513875 |
| 79 | cellular response to ethanol (GO:0071361) | 2.79053718 |
| 80 | T cell migration (GO:0072678) | 2.78140220 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 2.78136904 |
| 82 | negative regulation of cell killing (GO:0031342) | 2.77748106 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77748106 |
| 84 | myeloid dendritic cell differentiation (GO:0043011) | 2.74698323 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 2.74320498 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72459018 |
| 87 | response to host (GO:0075136) | 2.72459018 |
| 88 | response to host defenses (GO:0052200) | 2.72459018 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 2.71130843 |
| 90 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.70096785 |
| 91 | NIK/NF-kappaB signaling (GO:0038061) | 2.69016034 |
| 92 | response to protozoan (GO:0001562) | 2.68191288 |
| 93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67972577 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.67840119 |
| 95 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.67548997 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.67493584 |
| 97 | apoptotic cell clearance (GO:0043277) | 2.66939234 |
| 98 | regulation of integrin activation (GO:0033623) | 2.65833448 |
| 99 | low-density lipoprotein particle clearance (GO:0034383) | 2.65046980 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.64580663 |
| 101 | histone H3-K36 demethylation (GO:0070544) | 2.63903373 |
| 102 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.62699644 |
| 103 | leukocyte mediated cytotoxicity (GO:0001909) | 2.62377171 |
| 104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62084275 |
| 105 | germinal center formation (GO:0002467) | 2.60975593 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.60652514 |
| 107 | positive thymic T cell selection (GO:0045059) | 2.59616110 |
| 108 | dendritic cell migration (GO:0036336) | 2.59424126 |
| 109 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58613712 |
| 110 | T-helper 1 type immune response (GO:0042088) | 2.57946602 |
| 111 | cytokine secretion (GO:0050663) | 2.57239589 |
| 112 | dendritic cell differentiation (GO:0097028) | 2.57096459 |
| 113 | detection of molecule of bacterial origin (GO:0032490) | 2.55901351 |
| 114 | phospholipid homeostasis (GO:0055091) | 2.55267589 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54944256 |
| 116 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.54664089 |
| 117 | mature B cell differentiation (GO:0002335) | 2.53518104 |
| 118 | negative regulation of innate immune response (GO:0045824) | 2.53081477 |
| 119 | myeloid leukocyte activation (GO:0002274) | 2.52653835 |
| 120 | macrophage activation (GO:0042116) | 2.52527043 |
| 121 | regulation of mast cell activation (GO:0033003) | 2.52309702 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52153177 |
| 123 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49889514 |
| 124 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49842211 |
| 125 | leukocyte cell-cell adhesion (GO:0007159) | 2.49522334 |
| 126 | microglial cell activation (GO:0001774) | 2.49486319 |
| 127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49418009 |
| 128 | positive regulation of tolerance induction (GO:0002645) | 2.49082596 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.48782530 |
| 130 | mannose metabolic process (GO:0006013) | 2.47731326 |
| 131 | interferon-gamma secretion (GO:0072643) | 2.47235473 |
| 132 | I-kappaB phosphorylation (GO:0007252) | 2.47095790 |
| 133 | positive regulation of mast cell activation (GO:0033005) | 2.46802145 |
| 134 | tolerance induction (GO:0002507) | 2.46552062 |
| 135 | leukotriene metabolic process (GO:0006691) | 2.46360714 |
| 136 | cytidine catabolic process (GO:0006216) | 2.45603157 |
| 137 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.44465685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.86904203 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.93615866 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21879783 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.74219264 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66906875 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22608301 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16448589 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14383192 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13485548 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10726192 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.08904844 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97838696 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84159402 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43429150 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.41603004 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41355302 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36966885 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30232066 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.27382040 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26788825 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07750221 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06784142 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.03427280 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02640703 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01467599 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97342189 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94361476 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91953671 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90583980 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90230716 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87143784 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81157481 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78947355 |
| 34 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.76220213 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75940050 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74972103 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.73452892 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71210928 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70171227 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68079681 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.66459509 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.65931293 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.65315450 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57753099 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51012724 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50391273 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.47642841 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47497742 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46235442 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45783543 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45645421 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43045346 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42951094 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40193382 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40140687 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38112007 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37796595 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35309990 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35109283 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33628942 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32865653 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28058768 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.26769978 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26768391 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22440819 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21096590 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20419144 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18549170 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17872432 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16852028 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16699321 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15814795 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14645297 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12777482 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12033406 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11811224 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11183102 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09875675 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08585571 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08352341 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07515561 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03717667 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03452413 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03264976 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03218063 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02978084 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01845255 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01402765 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00659807 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00524251 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99800118 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99777976 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99727481 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99715496 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98552772 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98387903 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98377082 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98098875 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97765645 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96897637 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96897637 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96481111 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96411998 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95986049 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95772632 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93996079 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93453490 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92889022 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91160087 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.90498398 |
| 111 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90199546 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89713237 |
| 113 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89670699 |
| 114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.88171515 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87947004 |
| 116 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86575924 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86449307 |
| 118 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86335900 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83223479 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81845768 |
| 121 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81562386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.94097426 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.65162522 |
| 3 | MP0003436_decreased_susceptibility_to | 3.21818180 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.78796412 |
| 5 | MP0002419_abnormal_innate_immunity | 2.60335718 |
| 6 | MP0000685_abnormal_immune_system | 2.50586633 |
| 7 | MP0009785_altered_susceptibility_to | 2.47491944 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.41827264 |
| 9 | MP0005387_immune_system_phenotype | 2.41806687 |
| 10 | MP0001790_abnormal_immune_system | 2.41806687 |
| 11 | MP0005025_abnormal_response_to | 2.37880365 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.37202772 |
| 13 | MP0001800_abnormal_humoral_immune | 2.33391253 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.33197032 |
| 15 | MP0005671_abnormal_response_to | 2.16769720 |
| 16 | MP0003303_peritoneal_inflammation | 2.13307394 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.12811563 |
| 18 | MP0006082_CNS_inflammation | 2.12736369 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.11983232 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.11917697 |
| 21 | MP0005451_abnormal_body_composition | 2.11615265 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.11193144 |
| 23 | MP0002723_abnormal_immune_serum | 2.07417610 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.03847029 |
| 25 | MP0001819_abnormal_immune_cell | 1.94300011 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.91973448 |
| 27 | MP0009840_abnormal_foam_cell | 1.91426173 |
| 28 | MP0004510_myositis | 1.91289705 |
| 29 | MP0008260_abnormal_autophagy | 1.87587662 |
| 30 | MP0002006_tumorigenesis | 1.85945656 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.83668493 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.79404891 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.77525007 |
| 34 | MP0004947_skin_inflammation | 1.76679407 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.65534010 |
| 36 | MP0009278_abnormal_bone_marrow | 1.64821295 |
| 37 | MP0001873_stomach_inflammation | 1.64172646 |
| 38 | MP0003724_increased_susceptibility_to | 1.62790626 |
| 39 | MP0002405_respiratory_system_inflammati | 1.62078838 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.61002663 |
| 41 | MP0005360_urolithiasis | 1.54936340 |
| 42 | MP0001853_heart_inflammation | 1.50556727 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.49712306 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.49708721 |
| 45 | MP0000716_abnormal_immune_system | 1.44536899 |
| 46 | MP0002398_abnormal_bone_marrow | 1.41394707 |
| 47 | MP0010307_abnormal_tumor_latency | 1.40597803 |
| 48 | MP0008469_abnormal_protein_level | 1.40049790 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.37741056 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.37741056 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.34729291 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.33477175 |
| 53 | MP0004883_abnormal_blood_vessel | 1.33166852 |
| 54 | MP0003448_altered_tumor_morphology | 1.30420674 |
| 55 | MP0005310_abnormal_salivary_gland | 1.29495424 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.26227782 |
| 57 | MP0003866_abnormal_defecation | 1.23248684 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.21643600 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 1.20864379 |
| 60 | MP0000858_altered_metastatic_potential | 1.20521583 |
| 61 | MP0002429_abnormal_blood_cell | 1.19083073 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.18123893 |
| 63 | MP0000371_diluted_coat_color | 1.17371825 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.16354046 |
| 65 | MP0002722_abnormal_immune_system | 1.15670624 |
| 66 | MP0005164_abnormal_response_to | 1.15459114 |
| 67 | MP0009764_decreased_sensitivity_to | 1.14167330 |
| 68 | MP0004381_abnormal_hair_follicle | 1.13162469 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.12782537 |
| 70 | MP0005257_abnormal_intraocular_pressure | 1.11723683 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.08434168 |
| 72 | MP0002009_preneoplasia | 1.06767951 |
| 73 | MP0000490_abnormal_crypts_of | 1.05415022 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.04065288 |
| 75 | MP0002254_reproductive_system_inflammat | 1.04039554 |
| 76 | MP0003763_abnormal_thymus_physiology | 0.99562192 |
| 77 | MP0003690_abnormal_glial_cell | 0.96892246 |
| 78 | MP0002933_joint_inflammation | 0.95754346 |
| 79 | MP0006054_spinal_hemorrhage | 0.94291153 |
| 80 | MP0009763_increased_sensitivity_to | 0.93317127 |
| 81 | MP0005409_darkened_coat_color | 0.92618888 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.92013518 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.91504091 |
| 84 | MP0008004_abnormal_stomach_pH | 0.91269743 |
| 85 | MP0000609_abnormal_liver_physiology | 0.88536462 |
| 86 | MP0000343_altered_response_to | 0.88334163 |
| 87 | MP0010329_abnormal_lipoprotein_level | 0.87256860 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.87227913 |
| 89 | MP0003279_aneurysm | 0.87210612 |
| 90 | MP0001666_abnormal_nutrient_absorption | 0.87059875 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.86933311 |
| 92 | MP0003828_pulmonary_edema | 0.85947189 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.85896934 |
| 94 | MP0005166_decreased_susceptibility_to | 0.85672228 |
| 95 | MP0005670_abnormal_white_adipose | 0.84402976 |
| 96 | MP0001958_emphysema | 0.82639375 |
| 97 | MP0002060_abnormal_skin_morphology | 0.81414365 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.80385911 |
| 99 | MP0002132_abnormal_respiratory_system | 0.78619423 |
| 100 | MP0005390_skeleton_phenotype | 0.76714979 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.76422217 |
| 102 | MP0005023_abnormal_wound_healing | 0.76149538 |
| 103 | MP0003075_altered_response_to | 0.75629617 |
| 104 | MP0003045_fibrosis | 0.75541864 |
| 105 | MP0001663_abnormal_digestive_system | 0.75261072 |
| 106 | MP0003252_abnormal_bile_duct | 0.74050850 |
| 107 | MP0005365_abnormal_bile_salt | 0.73627172 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.73067461 |
| 109 | MP0003091_abnormal_cell_migration | 0.72823215 |
| 110 | MP0000604_amyloidosis | 0.71841762 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.71780831 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.71462690 |
| 113 | MP0001851_eye_inflammation | 0.70607050 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.70277892 |
| 115 | MP0009115_abnormal_fat_cell | 0.69300953 |
| 116 | MP0000249_abnormal_blood_vessel | 0.68984590 |
| 117 | MP0003795_abnormal_bone_structure | 0.68620126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.21189213 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.91021761 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.42321501 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.82372231 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.11355380 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.96396697 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93644454 |
| 8 | Myositis (HP:0100614) | 3.84991781 |
| 9 | Gingivitis (HP:0000230) | 3.82655882 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.73845248 |
| 11 | Periodontitis (HP:0000704) | 3.72939051 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.72383036 |
| 13 | Recurrent skin infections (HP:0001581) | 3.66032259 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.63007818 |
| 15 | Orchitis (HP:0100796) | 3.45423281 |
| 16 | Pustule (HP:0200039) | 3.44294323 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.39484835 |
| 18 | Recurrent viral infections (HP:0004429) | 3.23607125 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.22138431 |
| 20 | Optic neuritis (HP:0100653) | 3.22138431 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.18579977 |
| 22 | Myocardial infarction (HP:0001658) | 3.02757437 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91376050 |
| 24 | T lymphocytopenia (HP:0005403) | 2.90465593 |
| 25 | Abnormality of T cell number (HP:0011839) | 2.78751184 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.78053150 |
| 27 | Cellulitis (HP:0100658) | 2.77570191 |
| 28 | Colitis (HP:0002583) | 2.76653918 |
| 29 | Malnutrition (HP:0004395) | 2.75976381 |
| 30 | Vasculitis (HP:0002633) | 2.75302412 |
| 31 | Disinhibition (HP:0000734) | 2.73748925 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73699293 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73699293 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73699293 |
| 35 | Hematochezia (HP:0002573) | 2.72895964 |
| 36 | Encephalitis (HP:0002383) | 2.69185059 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68061272 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68061272 |
| 39 | Osteomyelitis (HP:0002754) | 2.65799822 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.61768983 |
| 41 | Axonal loss (HP:0003447) | 2.58541059 |
| 42 | Prostate neoplasm (HP:0100787) | 2.56953184 |
| 43 | Gingival bleeding (HP:0000225) | 2.56631029 |
| 44 | Arterial thrombosis (HP:0004420) | 2.52943736 |
| 45 | Osteolytic defects of the hand bones (HP:0009699) | 2.52386145 |
| 46 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.52386145 |
| 47 | Thick nail (HP:0001805) | 2.52023764 |
| 48 | Chest pain (HP:0100749) | 2.51735194 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51525799 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.51525799 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.50349142 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46811779 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46811779 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46811779 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.43354587 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.41766213 |
| 57 | Obstructive lung disease (HP:0006536) | 2.41646125 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41646125 |
| 59 | Premature loss of primary teeth (HP:0006323) | 2.41438441 |
| 60 | Glomerulonephritis (HP:0000099) | 2.37517348 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36419248 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.31415585 |
| 63 | Leukocytosis (HP:0001974) | 2.29168822 |
| 64 | Meningitis (HP:0001287) | 2.27504044 |
| 65 | Viral hepatitis (HP:0006562) | 2.24939752 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.22685724 |
| 67 | Gastrointestinal stroma tumor (HP:0100723) | 2.22495969 |
| 68 | Abnormality of T cells (HP:0002843) | 2.22195161 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.18622858 |
| 70 | Thin bony cortex (HP:0002753) | 2.13042390 |
| 71 | Urticaria (HP:0001025) | 2.12765848 |
| 72 | Chronic diarrhea (HP:0002028) | 2.12635412 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.11912799 |
| 74 | Loss of speech (HP:0002371) | 2.11181220 |
| 75 | Stomatitis (HP:0010280) | 2.10444128 |
| 76 | Pulmonary embolism (HP:0002204) | 2.10261628 |
| 77 | Nephritis (HP:0000123) | 2.08732538 |
| 78 | Chronic otitis media (HP:0000389) | 2.07492058 |
| 79 | IgM deficiency (HP:0002850) | 2.07022288 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.06751726 |
| 81 | Abnormality of the fingertips (HP:0001211) | 2.06515414 |
| 82 | Increased IgE level (HP:0003212) | 2.05184509 |
| 83 | Recurrent bronchitis (HP:0002837) | 2.05163972 |
| 84 | Spontaneous hematomas (HP:0007420) | 2.05100450 |
| 85 | Gastrointestinal infarctions (HP:0005244) | 2.04880817 |
| 86 | Peritonitis (HP:0002586) | 2.04003619 |
| 87 | Abnormality of complement system (HP:0005339) | 2.03988940 |
| 88 | Cheilitis (HP:0100825) | 2.03526898 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 2.01227640 |
| 90 | Pathologic fracture (HP:0002756) | 2.00375354 |
| 91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99379437 |
| 92 | Keratoconjunctivitis (HP:0001096) | 1.98786545 |
| 93 | Lymphopenia (HP:0001888) | 1.98619826 |
| 94 | Agnosia (HP:0010524) | 1.98574001 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.97170795 |
| 96 | Petechiae (HP:0000967) | 1.97010238 |
| 97 | Epistaxis (HP:0000421) | 1.96770858 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 1.96248294 |
| 99 | Restrictive lung disease (HP:0002091) | 1.95972836 |
| 100 | Emphysema (HP:0002097) | 1.95599790 |
| 101 | Granulocytopenia (HP:0001913) | 1.95374329 |
| 102 | Thoracic kyphosis (HP:0002942) | 1.95117542 |
| 103 | Amyloidosis (HP:0011034) | 1.95039030 |
| 104 | Hemoptysis (HP:0002105) | 1.93939988 |
| 105 | Spondylolisthesis (HP:0003302) | 1.93697185 |
| 106 | Subacute progressive viral hepatitis (HP:0006572) | 1.93451210 |
| 107 | Prolonged bleeding time (HP:0003010) | 1.93385568 |
| 108 | Eosinophilia (HP:0001880) | 1.93268127 |
| 109 | Bone pain (HP:0002653) | 1.92338654 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90623983 |
| 111 | Thrombocytosis (HP:0001894) | 1.89895655 |
| 112 | Cerebral aneurysm (HP:0004944) | 1.89733251 |
| 113 | Joint hemorrhage (HP:0005261) | 1.88351807 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 1.87720236 |
| 115 | Abnormal platelet function (HP:0011869) | 1.87600735 |
| 116 | Impaired platelet aggregation (HP:0003540) | 1.87600735 |
| 117 | Thyroiditis (HP:0100646) | 1.85992409 |
| 118 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83995677 |
| 119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83029444 |
| 120 | Abnormality of the thoracic spine (HP:0100711) | 1.82793201 |
| 121 | Abnormality of the pleura (HP:0002103) | 1.82613837 |
| 122 | Skin ulcer (HP:0200042) | 1.82057849 |
| 123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81942603 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.80807981 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.78251932 |
| 126 | Verrucae (HP:0200043) | 1.77683338 |
| 127 | Papilloma (HP:0012740) | 1.77683338 |
| 128 | Abnormality of the endocardium (HP:0004306) | 1.77349578 |
| 129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76939861 |
| 130 | Frequent falls (HP:0002359) | 1.74883916 |
| 131 | Complement deficiency (HP:0004431) | 1.73812500 |
| 132 | Hypercholesterolemia (HP:0003124) | 1.73624564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.54040933 |
| 2 | MAP3K14 | 3.06941082 |
| 3 | TYK2 | 3.05363757 |
| 4 | IRAK3 | 2.72275900 |
| 5 | RIPK4 | 2.69876157 |
| 6 | IRAK4 | 2.69664682 |
| 7 | TBK1 | 2.68235971 |
| 8 | KIT | 2.65326176 |
| 9 | PRPF4B | 2.64130728 |
| 10 | TAOK3 | 2.62637545 |
| 11 | ERN1 | 2.40054963 |
| 12 | BLK | 2.37609084 |
| 13 | JAK3 | 2.11924029 |
| 14 | IKBKE | 1.96262018 |
| 15 | JAK1 | 1.93433295 |
| 16 | IKBKB | 1.84566581 |
| 17 | NEK9 | 1.81693754 |
| 18 | CAMK1D | 1.78441764 |
| 19 | TTN | 1.74191385 |
| 20 | TGFBR2 | 1.73441809 |
| 21 | CSF1R | 1.68064235 |
| 22 | ZAP70 | 1.61476425 |
| 23 | FRK | 1.53348236 |
| 24 | RIPK1 | 1.46009253 |
| 25 | CDC42BPA | 1.44864755 |
| 26 | CSK | 1.44557908 |
| 27 | MAP2K3 | 1.41663911 |
| 28 | STK10 | 1.38359633 |
| 29 | CDK12 | 1.37883131 |
| 30 | BTK | 1.36780339 |
| 31 | CHUK | 1.34423561 |
| 32 | TXK | 1.33700837 |
| 33 | EPHB1 | 1.32346440 |
| 34 | SYK | 1.31467859 |
| 35 | HCK | 1.29583402 |
| 36 | CAMK1G | 1.25364946 |
| 37 | FGFR4 | 1.23848572 |
| 38 | TEC | 1.23619318 |
| 39 | TRIB3 | 1.22750990 |
| 40 | TNK2 | 1.22265850 |
| 41 | PTK6 | 1.20841618 |
| 42 | NME2 | 1.19625920 |
| 43 | MAP3K10 | 1.18037846 |
| 44 | FGFR3 | 1.16717600 |
| 45 | PIM1 | 1.15730796 |
| 46 | MAP3K13 | 1.14025122 |
| 47 | FLT3 | 1.13877357 |
| 48 | MAP3K1 | 1.08122574 |
| 49 | MAP3K7 | 1.07571627 |
| 50 | TRPM7 | 1.06865696 |
| 51 | MARK2 | 1.06381358 |
| 52 | PIM2 | 1.05450367 |
| 53 | LCK | 1.04971985 |
| 54 | TAOK1 | 1.03941685 |
| 55 | CDK6 | 1.03858987 |
| 56 | RPS6KA4 | 1.03292066 |
| 57 | ITK | 1.00385174 |
| 58 | MST1R | 1.00099727 |
| 59 | MAP3K3 | 0.99494903 |
| 60 | JAK2 | 0.98769552 |
| 61 | SMG1 | 0.98493835 |
| 62 | PKN2 | 0.95413893 |
| 63 | LYN | 0.92810831 |
| 64 | IRAK1 | 0.90624266 |
| 65 | BMPR2 | 0.88904600 |
| 66 | GRK6 | 0.87279568 |
| 67 | PDPK1 | 0.85915984 |
| 68 | PRKD2 | 0.85558350 |
| 69 | MST4 | 0.84873430 |
| 70 | MARK3 | 0.83867271 |
| 71 | FES | 0.81107575 |
| 72 | KSR2 | 0.80513824 |
| 73 | STK4 | 0.79834495 |
| 74 | SIK1 | 0.79554970 |
| 75 | MAPK7 | 0.79306699 |
| 76 | MAP3K2 | 0.78033355 |
| 77 | ICK | 0.78005841 |
| 78 | LRRK2 | 0.77796654 |
| 79 | PIK3CG | 0.76712739 |
| 80 | MATK | 0.76560471 |
| 81 | CLK1 | 0.72584665 |
| 82 | NUAK1 | 0.71501044 |
| 83 | HIPK2 | 0.70596594 |
| 84 | MAP3K6 | 0.70434035 |
| 85 | MAP3K11 | 0.68921526 |
| 86 | MAPK12 | 0.68107658 |
| 87 | RET | 0.67589160 |
| 88 | SGK3 | 0.66697320 |
| 89 | ACVR1B | 0.65619598 |
| 90 | SIK3 | 0.59973736 |
| 91 | PAK4 | 0.58601160 |
| 92 | STK3 | 0.57598826 |
| 93 | CDK9 | 0.56878490 |
| 94 | ABL1 | 0.55464477 |
| 95 | MELK | 0.55181238 |
| 96 | MAP2K6 | 0.54426972 |
| 97 | EPHA3 | 0.53291029 |
| 98 | BMX | 0.53161020 |
| 99 | MAPK11 | 0.53129260 |
| 100 | DMPK | 0.52277964 |
| 101 | EEF2K | 0.51464974 |
| 102 | PRKG2 | 0.50840534 |
| 103 | EGFR | 0.50823872 |
| 104 | CDK4 | 0.50639082 |
| 105 | WNK1 | 0.50189778 |
| 106 | SIK2 | 0.49613129 |
| 107 | SCYL2 | 0.48514977 |
| 108 | SGK2 | 0.48173665 |
| 109 | FYN | 0.47077232 |
| 110 | IRAK2 | 0.44938494 |
| 111 | YES1 | 0.44327024 |
| 112 | CAMKK1 | 0.44057045 |
| 113 | RPS6KA6 | 0.43164198 |
| 114 | MAPKAPK2 | 0.41576752 |
| 115 | PDGFRB | 0.41320039 |
| 116 | PRKCD | 0.39846201 |
| 117 | PRKAA2 | 0.37424618 |
| 118 | FGR | 0.36850002 |
| 119 | STK24 | 0.36708044 |
| 120 | NLK | 0.35495132 |
| 121 | PRKCQ | 0.34841376 |
| 122 | NEK2 | 0.34006639 |
| 123 | RPS6KL1 | 0.33920878 |
| 124 | RPS6KC1 | 0.33920878 |
| 125 | DYRK1B | 0.33101599 |
| 126 | MTOR | 0.32294909 |
| 127 | BRD4 | 0.31123183 |
| 128 | PTK2 | 0.30192540 |
| 129 | MAP3K8 | 0.29742132 |
| 130 | PDK1 | 0.29284292 |
| 131 | RPS6KA2 | 0.28101465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.00093145 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.88174975 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.50288952 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43500638 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39570530 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.37029367 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28937068 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09022786 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.06448272 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.05030422 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.99805334 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.98110074 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.97224592 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96187695 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.93227519 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.91671764 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.89357953 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78881021 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74514133 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.67380176 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64401356 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.63975353 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.63065812 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56822738 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49342072 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47987815 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47692989 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36708996 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.36136738 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.31987531 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31161831 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29393086 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28784295 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.28593064 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27063238 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23756117 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23355074 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.21991362 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.19926911 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15038095 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11842396 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11013724 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10569854 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08892958 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.07730768 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.04046453 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99560955 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98230484 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97789003 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.97572895 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.94679620 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93527102 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93038529 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92801338 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92695720 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88344545 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88330372 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86015741 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84644182 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.84086096 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83468049 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82482544 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82377193 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81895478 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.81408492 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80067022 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.79154037 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78659433 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77974191 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75917446 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.74882243 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74656150 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.74088847 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72825604 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72689891 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.71680478 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71401511 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71374757 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69094505 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68548767 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66877079 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64672382 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64373252 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63099873 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60156692 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59580092 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58045204 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56771227 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54970052 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.53087760 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50757558 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50685809 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50597671 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49491555 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.48907271 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48897057 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48549695 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47914672 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47497359 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47198098 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46941098 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46312485 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45721595 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44990127 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44523992 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43858154 |
| 107 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43715394 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42578516 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42463092 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41797987 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40618409 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.40423508 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40160254 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39715761 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39441238 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39406115 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38710914 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.36785928 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35953667 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34664058 |
| 121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34056870 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32623053 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32097945 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.30679903 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30227256 |

